Prevalence of hepatitis C in South Africa: Detection of anti-HCV in recent and stored serum
โ Scribed by L. A. Ellis; D. Brown; J. D. Conradie; A. Paterson; R. Sher; J. Millo; E. Theodossiadou; G. M. Dusheiko
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 379 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The prevalence of antiโHCV was studied in a cohort of 2,072 South Africans. The results were compared in selected recently collected sera and in stored sera. The serum ALT and antiโHBc were also studied as surrogate markers in this population. The following groups were tested: (a) 948 urban, black blood donors (b) 500 white blood donors (c) 500 Asian blood donors (d) 216 rural hospitalized patients (e) 358 rural mineworkers. Sera found positive by the original ELISA were retested, and reproducibly positive tests in rural black men (group d) were confirmed both by recombinant immunoblot assay and by a second ELISA. An antiโHCV prevalence of 1.2%, 0.8%, and 0.6% in urban blacks, Asians, and whites was found. Antibodies to hepatitis B core antigen were found in 42.9%, 3.4%, and 1.2% of black, Asian, and white donors, respectively; 76% of donors positive for antiโHCV were antiโHBc negative. In rural African men, 17% of stored serum samples and 9.2% of recently collected serum samples were positive for antiโHCV. In this cohort 3.84% were positive by all three assays. These results suggest that the prevalence of antiโHCV in low and highโrisk South African urban blood donors is comparable to high and low prevalence areas in Europe, the United States, and Japan, but indicates a relatively high degree of exposure to hepatitis C in rural African men. The reactivity of stored, frozen sera in this population requires further investigation. In South African urban blood donors, surrogate marker testing will not expedite HCV screening.
๐ SIMILAR VOLUMES
Very little is known about the distribution of hepatitis C virus (HCV) within South America. To assess the exposure of the general population to this virus, a number of sera obtained from three distinct geographical and racial groups were screened using a combination of immunoassays. Initial screeni
Approximately 90% of subjects with chronic hepatitis resulting from hepatitis C virus infection have hepatitis C virus RNA in serum. However, the prevalence of hepatitis C virus RNA in serum from subjects with hepatitis C virus antibody associated with persistent normal liver biochemical values is u
## Abstract Partial nucleotide sequences in the core region of the hepatitis C viral genome were determined by reverse transcription followed by polymerase chain reaction, in a patient with chronic hepatitis from South Africa. These nucleotide sequences showed a low degree of homology with known ty
Serum samples from 103 blood donors or patients with slightly increased serum levels of liver enzymes were tested for antibodies to hepatitis C virus (anti-HCV) using second generation tests and for HCV RNA by the polymerase chain reaction (PCR). PCR was in a nested configuration, using primer pairs
## Abstract A new, sensitive enzyme immunoassay has been developed for detecting and quantifying total hepatitis C virus (HCV) core antigen in antiโHCV positive or negative sera (โ__trak__โ__C__โขโ, Ortho Clinical Diagnostics, Raritan, NJ). The purpose of this study was to evaluate the performance o